Needham analyst David Saxon maintains SI-BONE (NASDAQ:SIBN) with a Buy and lowers the price target from $28 to $24.
Armata Pharmaceuticals Q3 EPS $(0.22) Up From $(0.31) YoY, Sales $1.25M Up From $288.00K YoY
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.22) per share. This is a 29.03 percent increase over losses of $(0.31) per share from the same period last year. The company reported $1.25 million in
